$OGEN SEC Filings

Filed On	Filing
16 Sep 2026	8-K: Regulation FD Disclosure; Other Events Presentation Highlights Clinical Translation of ONP-002 Intranasal Delivery Platform for Concussion Treatment
28 Aug 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Other Events
13 Aug 2026	10-Q
07 Jul 2026	Form 4: Spencer John, Chief Financial Officer Granted 55,900 Employee Stock Option (right to buy)
07 Jul 2026	Form 3: Spencer John, Chief Financial Officer Holds 53 shares of Common Stock
06 Jul 2026	8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation +1 more
20 May 2026	DEFA14A
20 May 2026	Proxy statement: annual meeting on June 29, 2026 CEO pay $609K, up 67% · say-on-pay vote
19 May 2026	8-K: Regulation FD Disclosure; Other Events
08 May 2026	PRE 14A
08 May 2026	10-Q
07 May 2026	8-K: Other Events
13 Apr 2026	8-K: Other Events
31 Mar 2026	8-K: Shareholder Director Nominations
20 Mar 2026	EFFECT
19 Mar 2026	CORRESP
19 Mar 2026	S-3/A
16 Mar 2026	10-K
11 Mar 2026	8-K: Other Events
27 Jan 2026	UPLOAD

Comments